BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12239600)

  • 1. Myristoyl-CoA:protein N-myristoyltransferase: a novel molecular approach for cancer therapy (Review).
    Selvakumar P; Pasha MK; Ashakumary L; Dimmock JR; Sharma RK
    Int J Mol Med; 2002 Oct; 10(4):493-500. PubMed ID: 12239600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential role of N-myristoyltransferase in cancer.
    Selvakumar P; Lakshmikuttyamma A; Shrivastav A; Das SB; Dimmock JR; Sharma RK
    Prog Lipid Res; 2007 Jan; 46(1):1-36. PubMed ID: 16846646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of N-myristoyltransferase by novel inhibitor proteins.
    Shrivastav A; Selvakumar P; Bajaj G; Lu Y; Dimmock JR; Sharma RK
    Cell Biochem Biophys; 2005; 43(1):189-202. PubMed ID: 16043893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of N-myristoyltransferase in gallbladder carcinomas.
    Rajala RV; Radhi JM; Kakkar R; Datla RS; Sharma RK
    Cancer; 2000 May; 88(9):1992-9. PubMed ID: 10813869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent inhibitor of N-myristoylation: a novel molecular target for cancer.
    Shrivastav A; Pasha MK; Selvakumar P; Gowda S; Olson DJ; Ross AR; Dimmock JR; Sharma RK
    Cancer Res; 2003 Nov; 63(22):7975-8. PubMed ID: 14633729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-Myristoyltransferase overexpression in human colorectal adenocarcinomas.
    Raju RV; Moyana TN; Sharma RK
    Exp Cell Res; 1997 Aug; 235(1):145-54. PubMed ID: 9281363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Akt/PKB modulates N-myristoyltransferase activity in cancer cells.
    Shrivastav A; Varma S; Senger A; Khandelwal RL; Carlsen S; Sharma RK
    J Pathol; 2009 Jul; 218(3):391-8. PubMed ID: 19360752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclohexyl-octahydro-pyrrolo[1,2-a]pyrazine-based inhibitors of human N-myristoyltransferase-1.
    French KJ; Zhuang Y; Schrecengost RS; Copper JE; Xia Z; Smith CD
    J Pharmacol Exp Ther; 2004 Apr; 309(1):340-7. PubMed ID: 14724220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased N-myristoyltransferase activity observed in rat and human colonic tumors.
    Magnuson BA; Raju RV; Moyana TN; Sharma RK
    J Natl Cancer Inst; 1995 Nov; 87(21):1630-5. PubMed ID: 7563206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated N-myristoyltransferase activity and expression in oral squamous cell carcinoma.
    Shrivastav A; Sharma AR; Bajaj G; Charavaryamath C; Ezzat W; Spafford P; Gore-Hickman R; Singh B; Copete MA; Sharma RK
    Oncol Rep; 2007 Jul; 18(1):93-7. PubMed ID: 17549352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of N-myristoyltransferase inhibitor protein and its relationship to c-Src levels in human colon cancer cell lines.
    Rajala RV; Dehm S; Bi X; Bonham K; Sharma RK
    Biochem Biophys Res Commun; 2000 Jul; 273(3):1116-20. PubMed ID: 10891381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myristoyl CoA:protein N-myristoyltransferase: subcellular localization, activation and kinetic behavior in the presence of organic solvents.
    Rajala RV; Sharma RK
    Biochem Biophys Res Commun; 1995 Mar; 208(2):617-23. PubMed ID: 7695615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of calpain and caspase system in the regulation of N-myristoyltransferase in human colon cancer (Review).
    Selvakumar P; Sharma RK
    Int J Mol Med; 2007 May; 19(5):823-7. PubMed ID: 17390089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myristoyl-CoA:protein N-myristoyltransferases: isoform identification and gene expression in retina.
    Rundle DR; Rajala RV; Alvarez RA; Anderson RE
    Mol Vis; 2004 Mar; 10():177-85. PubMed ID: 15041955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the discovery of N-myristoyltransferase inhibitors.
    Zhao C; Ma S
    ChemMedChem; 2014 Nov; 9(11):2425-37. PubMed ID: 25125080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role of N-myristoyltransferase in pathogenic conditions.
    Sharma RK
    Can J Physiol Pharmacol; 2004 Oct; 82(10):849-59. PubMed ID: 15573145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of L-histidine and its structural analogues on human N-myristoyltransferase activity and importance of EEVEH amino acid sequence for enzyme activity.
    Raju RV; Datla RS; Warrington RC; Sharma RK
    Biochemistry; 1998 Oct; 37(42):14928-36. PubMed ID: 9778369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemical characterization and subcellular localization of human myristoyl-CoA: protein N-myristoyltransferase in HeLa cells.
    McIlhinney RA; McGlone K
    Exp Cell Res; 1996 Mar; 223(2):348-56. PubMed ID: 8601412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-myristoyltransferase 2 expression in human colon cancer: cross-talk between the calpain and caspase system.
    Selvakumar P; Smith-Windsor E; Bonham K; Sharma RK
    FEBS Lett; 2006 Apr; 580(8):2021-6. PubMed ID: 16530191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential activation of bovine brain N-myristoyltransferase(s) by a cytosolic activator.
    King MJ; Sharma RK
    Biochem Biophys Res Commun; 1995 Jul; 212(2):580-8. PubMed ID: 7626073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.